Abiopharma

Clinical trial NCT05348733 updates: 1. completion date: 2027-12-15 → 2026-12-22 2. primary completion date: 2027-09-01 → 2026-11-05

Clinical trial NCT05298423: primary completion date: 2026-08-19 → 2026-06-15.

Clinical trial NCT07571161 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-04-30

Clinical trial NCT06228755 updates: 1. completion date: 2026-12-01 → 2027-06-01 2. primary completion date: 2026-12-01 → 2027-06-01

Clinical trial NCT06157541 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-04-01 → 2025-10-02

Clinical trial NCT06598306: primary completion date: 2027-03-03 → 2027-04-24.

Clinical trial NCT07023341: completion date: 2028-05-30 → 2028-04-28.

Clinical trial NCT06229834: primary completion date: 2026-04-01 → 2027-04-01.

Clinical trial NCT07154901 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment: 34 → 35 participants

Clinical trial NCT03152669 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2028-04-30 → 2025-07-05 3. primary completion date: 2028-04-30 → 2025-07-05 4. enrollment: 3500 → 1183 participants 5. enrollment type: ESTIMATED → ACTUAL